- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Available Recombinant, and Human Factor VIII products incl. Kogenate FS (Recombinant Factor VIII, BA
Total 193 results
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Acquired HaemophiliaFrance
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance, United States, Spain, Brazil, Philippines, South Africa, Poland, Turkey, Romania, Bulgaria, Russian Federation, Argentina
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BBelgium, Germany, France, United Kingdom, Italy, Hungary, Austria, Sweden, Iran, Islamic Republic of, Argentina, Ireland, Poland, Portugal, Slovakia
-
Baxalta now part of ShireCompletedHemophilia A | Hemophilia BUnited States
-
TakedaCompleted
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, United Kingdom, Bulgaria, Lithuania, Russian Federation, Switzerland, Ukraine
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedAcquired Hemophilia AUnited States
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Bleeding During/Following SurgeryGermany, Sweden, United Kingdom, Spain, Canada, Australia, France
-
Novo Nordisk A/SCompletedCirrhosis | Acquired Bleeding DisorderTaiwan, Thailand, China
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary BypassAustralia
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Dengue Haemorrhagic FeverMalaysia, Philippines, Thailand
-
Jiangsu Gensciences lnc.Not yet recruitingSevere Hemophilia AChina
-
St. James's Hospital, IrelandBaxter BioScienceUnknownSevere Haemophilia AIreland
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Acquired Bleeding Disorder | Acquired Haemophilia | Congenital FVII Deficiency | Glanzmann's DiseaseGermany
-
Bioverativ Therapeutics Inc.CompletedHemophilia AUnited States, Canada, Italy, Australia, Austria, Belgium, Brazil, France, Germany, Hong Kong, India, Ireland, Israel, Japan, Netherlands, New Zealand, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Jiangsu Gensciences lnc.RecruitingSevere Hemophilia AChina
-
City of Hope Medical CenterCSL Behring; Grifols Therapeutics LLC; Grifols Biologicals, LLC; Charta Foundation and other collaboratorsWithdrawn
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BSpain
-
BayerActive, not recruiting
-
Baxalta now part of ShireCompletedHemophilia AUnited States, France, Austria, United Kingdom, Germany, Belgium, Canada, Italy, Sweden
-
Baxalta now part of ShireCompletedHemophilia AUnited States
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Canada, Puerto Rico
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia AUnited States, Belgium, France, Norway, Netherlands, Austria, Hungary, Italy, Poland, Portugal, Romania, Russian Federation, Spain, Sweden
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSaudi Arabia, Algeria, Turkey, Germany, Poland, Netherlands, Italy, Belgium, South Africa, United Kingdom, Sweden, Austria, Portugal, France, Czech Republic, Venezuela
-
Sheba Medical CenterUnknown
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States, Denmark, France, United Kingdom
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Poland, Slovenia, Greece, Russian Federation, Hungary, Italy, United Kingdom, Czechia, Austria
-
Oregon Health and Science UniversityBaxter Healthcare CorporationCompleted
-
Spanish Society of Thrombosis and HaemostasisTakeda; Instituto de Investigación Hospital Universitario La PazCompletedHemophilia A | Hemophilia | Factor VIII DeficiencySpain
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSlovakia, Spain, Argentina, Germany, Croatia, Italy, Canada, United Kingdom, Ireland, Sweden, France, United States, Czech Republic, Switzerland
-
Baxalta now part of ShireCompletedHemophilia AUnited States, France, United Kingdom, Spain, Germany, Canada, Puerto Rico, Italy, Sweden, Austria
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, Australia, Czechia, Korea, Republic of, Taiwan, Poland, Bulgaria, United Kingdom, Germany, Turkey, Israel, Malaysia, Ukraine, Russian Federation, Austria, Switzerland, Japan, Hong Kong, Lithuania, Roman... and more
-
Laboratoire français de Fractionnement et de BiotechnologiesRecruitingHemophiliaUnited States, Thailand, Malaysia, Mexico, Turkey, South Africa
-
Laboratoire français de Fractionnement et de BiotechnologiesLFB USA, Inc.CompletedHemophiliaUnited States, Ukraine, Mexico, Russian Federation, South Africa, Spain
-
rEVO BiologicsLaboratoire français de Fractionnement et de BiotechnologiesCompletedHemophilia A With Inhibitors | Hemophilia B With InhibitorsUnited States, Bulgaria, Poland, Russian Federation, Belarus, Georgia, Israel, Romania, Ukraine, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance, United States, Sweden, Serbia, Turkey, United Kingdom, Malaysia, Brazil, Former Serbia and Montenegro, Japan, South Africa
-
Baxalta now part of ShireCompleted
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.Active, not recruitingHemophilia ASpain, United States, Denmark, Italy, Taiwan, Malaysia, Belgium, Thailand, Turkey, Austria, Bulgaria, Canada, Finland, France, Germany, Hong Kong, Hungary, Korea, Republic of, Netherlands, Norway, Singapore, Ukraine, United Kingdom
-
Baxalta now part of ShireCompletedHemophilia ASpain, Bulgaria, Germany, United Kingdom, Italy, Poland, Russian Federation, Netherlands, Hungary
-
PfizerCompletedHemophilia AKorea, Republic of
-
rEVO BiologicsCompletedHemophiliaNetherlands, United States
-
Baxalta now part of ShireCompleted
-
BayerRecruitingHemophilia A | Prophylaxis of BleedingUnited States
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderUnited Kingdom
-
TakedaActive, not recruiting
-
Baxalta now part of ShireBaxter Innovations GmbHTerminatedHemophilia APoland, United States, Bulgaria, Serbia, Canada, Russian Federation, Germany, Netherlands, Lithuania, Czechia, Austria, Spain
-
University of AarhusCompleted
-
Baxalta now part of ShireCompletedRecombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand RegimenHemophilia A | Hemophilia BJapan, Russian Federation, Spain, United States, Poland, Romania, Serbia, Taiwan, Ukraine
-
American Thrombosis and Hemostasis NetworkLFB USA, Inc.RecruitingHemophilia A With Inhibitor | Hemophilia B With InhibitorUnited States